Evidence map›Paper›PMID 34672874›Full record

ArticleVirulence2021

Sequence variations in the ETEC CS6 operon affect transcript and protein expression.

Jonathan Moon, Eileen M Barry

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jonathan MoonCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA.
Eileen M BarryCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-5326-0047
University of Maryland, Baltimore · US

Funding

Shigella Live Vector-Based Multivalent VaccineU19AI109776 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2014 to 2018
$25.4M
Probiotic yeast secreting single-domain antibodies to prevent Clostridium difficile and Campylobacter jejuni diseaseU19AI142725 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2019 to 2023
$12.5M
NIAID NIH HHS U19 AI109776NIAID NIH HHS U19 AI142725
6 · The paper itself

Abstract

Enterotoxigenic

Indexed as

Antigens, BacterialEnterotoxigenic Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsDiarrheaEnterotoxinsOperonTravelAntigens, BacterialCS6 antigen, E coliEnterotoxinsEscherichia coli ProteinsCS6ETECexpressionregulationvaccine

Identifiers

PMID34672874
PMCPMC8923064
OpenAlexW3207126896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.